Performance analysis of Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) (DMAAU)
Annual Return
Since Jan 28, 2025, DMAAU has had an average annual return of +5.01%, underperforming the benchmark SPY, which returned +19.14% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.81% | +4.90% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.57% | -0.47% | +0% | +0.76% | +1.23% | -0.28% | +1.81% | ||||||
| 2025 | +0.15% | +1.85% | -0.29% | +0.22% | +1.06% | +0.19% | +2.52% | +0.19% | -1.89% | +0.77% | +0.10% | +0% | +4.90% |
Drawdown analysis of Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) (DMAAU)
The maximum drawdown for the DMAAU was -3.35%, occurring on Jun 3, 2026. This drawdown has not yet recovered.
The current DMAAU drawdown is -3.35%.
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -3.35% | Jun 2, 2026 | 1 | Jun 3, 2026 | Ongoing | Ongoing | Ongoing |
| -2.17% | Aug 5, 2025 | 33 | Sep 22, 2025 | 167 | May 21, 2026 | 200 |
| -2.10% | Jun 2, 2025 | 2 | Jun 4, 2025 | 37 | Jul 29, 2025 | 39 |
| -1.93% | May 21, 2026 | 2 | May 26, 2026 | 5 | Jun 2, 2026 | 7 |
| -0.98% | Feb 28, 2025 | 6 | Mar 10, 2025 | 35 | Apr 29, 2025 | 41 |
| -0.29% | Apr 29, 2025 | 3 | May 2, 2025 | 2 | May 6, 2025 | 5 |
| -0.20% | Feb 14, 2025 | 1 | Feb 18, 2025 | 3 | Feb 21, 2025 | 4 |
| -0.10% | May 13, 2025 | 1 | May 14, 2025 | 1 | May 15, 2025 | 2 |
| -0.05% | Jan 30, 2025 | 1 | Jan 31, 2025 | 2 | Feb 4, 2025 | 3 |
| -0.05% | Feb 4, 2025 | 1 | Feb 5, 2025 | 2 | Feb 7, 2025 | 3 |
| -0.05% | Feb 24, 2025 | 1 | Feb 25, 2025 | 3 | Feb 28, 2025 | 4 |
| -0.04% | Feb 11, 2025 | 1 | Feb 12, 2025 | 2 | Feb 14, 2025 | 3 |
| -0.01% | May 6, 2025 | 2 | May 8, 2025 | 3 | May 13, 2025 | 5 |